Tech Company Financing Transactions
NanoPass Funding Round
NanoPass closed a Series B funding round on 7/30/2012. Investors included Israel Healthcare Ventures and private investors.
Transaction Overview
Company Name
Announced On
7/30/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Israel Healthcare Ventures (Lead Investor) (Hadar Ron)
Proceeds Purpose
The capital raised will be used to accelerate the market penetration of NanoPass' leading applications through additional licenses with pharmaceutical companies.
Company Information
Company Status
Private & Independent
Industry
Nanotechnology
Mailing Address
3 Golda Meir St.
Ness Ziona, 7403648
Israel
Ness Ziona, 7403648
Israel
Phone
Website
Email Address
Overview
NanoPass Technologies Ltd. was founded in 2000 by Dr. Shuki Yeshurun, a material scientist and an expert in micro system technology (MEMS). Dr. Yeshurun has developed a unique design of microneedles in silicon wafers. Based on this MicroPyramid design, NanoPass is developing devices for intradermal delivery and cosmetic enhancement.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yotam Levin
Chief Medical Officer
Efrat Kochba
Chief Operating Officer
Gal Admati
VP - Operations
Yoav Hamisha
VP - Regulatory Affairs
Ruth Safdia
VP - Sales
Yarin Sinai
Browse more venture capital transactions:
Prev: 7/30/2012: Carbon Black venture capital transaction
Next: 7/30/2012: Funium venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs